Core Insights - The conference focused on how AI can reshape the value growth curve of Hong Kong-listed companies, emphasizing collaboration and innovation in the industry [1] Group 1: AI Empowering R&D Innovation - AI technology is driving significant momentum for traditional industry upgrades and breakthroughs in emerging technologies [2] - Companies like MiRui are leveraging AI in cancer screening, with AI models gradually replacing traditional statistical models, leading to improved accuracy in early cancer diagnosis [2] - TianGong International has invested nearly 30 million yuan in AI technology over the past three years, transitioning from imitation to innovation in high-end materials [2] - AI has enhanced the efficiency of research and development processes, allowing for faster molecular sequence design and analysis [3] Group 2: Optimizing Business Operations - China National Pharmaceutical Group has established a comprehensive pharmaceutical distribution network, utilizing AI to enhance operational efficiency and customer experience [4] - AI applications include intelligent warehousing, compliance with medical insurance regulations, and patient management services, significantly improving internal operations [4] - MiRui's AI platform facilitates professional training and enhances the interpretation of genetic data reports for clients [5] - AI is also used in vaccine production to ensure compliance with regulatory standards and improve quality management [5] Group 3: Building Sustainable AI Drivers - The integration of AI across industries presents both opportunities for efficiency and challenges for deep integration [6] - Companies must convert AI's potential into sustainable core drivers to maintain competitive advantages [6] - The strategic planning for the 14th Five-Year Plan emphasizes the importance of AI technology in business development [7] - Collaboration with leading AI firms is seen as essential for widespread application of AI in the industry [7]